tiprankstipranks
Trending News
More News >

InhaleRx Limited Announces Cessation of Securities

Story Highlights
InhaleRx Limited Announces Cessation of Securities

Confident Investing Starts Here:

InhaleRx Limited ( (AU:IRX) ) just unveiled an announcement.

InhaleRx Limited announced the cessation of 250,000 securities due to the expiry of options or other convertible securities without exercise or conversion as of February 28, 2025. This development may impact the company’s capital structure and could influence investor perceptions, potentially affecting its market positioning and stakeholder interests.

More about InhaleRx Limited

InhaleRx Limited operates in the pharmaceutical industry, focusing on the development and distribution of inhalation-based therapeutic products. The company is known for its innovative approach to drug delivery systems, targeting various medical conditions through inhalation technology.

YTD Price Performance: -34.29%

Average Trading Volume: 104,740

Technical Sentiment Consensus Rating: Strong Buy

Current Market Cap: A$4.91M

Find detailed analytics on IRX stock on TipRanks’ Stock Analysis page.

Disclaimer & Disclosure

Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.

Report an Issue

Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App
1